{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:45:38Z","timestamp":1783637138780,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","award":["203309"],"award-info":[{"award-number":["203309"]}],"id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe current practice in diagnosis and management of sarcopenia in older people in the United Kingdom (UK).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthcare professionals from UK organisations were invited to complete an online survey about sarcopenia diagnosis and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and one responses were analysed. Respondents represented a range of professional groups across 62 organisations from secondary care, primary care, community providers and private practitioners. Sarcopenia was identified in only 32\/62 (52%) organisations. Within these organisations, 17\/32 (53%) did not use a recognised algorithm for diagnosis, although 31\/32 (97%) of organisations assessed muscle strength. Twenty-nine (91%) organisations reported offering interventions to people diagnosed with sarcopenia, but resistance training was offered by only 19 (59%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This survey has shown that just over 50% of respondent organisations in the UK are identifying sarcopenia in older people as part of clinical practice, highlighting the need for ongoing work to achieve further improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-025-01321-w","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:43:39Z","timestamp":1759819419000},"page":"1059-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are we making progress in the diagnosis and management of sarcopenia? Results from a UK-wide survey"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-6599","authenticated-orcid":false,"given":"Christopher","family":"Hurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-9952","authenticated-orcid":false,"given":"Claire","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-5720","authenticated-orcid":false,"given":"Rachel","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1283-6457","authenticated-orcid":false,"given":"Avan A.","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-0990","authenticated-orcid":false,"given":"Miles D.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393:2636\u20132646. https:\/\/doi.org\/10.1016\/S0140-6736(19)31138-9","journal-title":"Lancet"},{"key":"1321_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","volume":"10","author":"AA Sayer","year":"2024","unstructured":"Sayer AA, Cooper R, Arai H, Cawthon PM, Ntsama Essomba M-J, Fielding RA et al (2024) Sarcopenia. Nat Rev Dis Primers 10:68. https:\/\/doi.org\/10.1038\/s41572-024-00550-w","journal-title":"Nat Rev Dis Primers"},{"key":"1321_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s41999-024-01132-5","volume":"16","author":"EG Lewis","year":"2025","unstructured":"Lewis EG, Hurst C, Errington L, Sayer AA (2025) Perceptions of sarcopenia in patients, health and care professionals, and the public: a scoping review of studies from different countries. Eur Geriatr Med 16:99\u2013113. https:\/\/doi.org\/10.1007\/s41999-024-01132-5","journal-title":"Eur Geriatr Med"},{"key":"1321_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/jgs.18227","volume":"71","author":"JM Guralnik","year":"2023","unstructured":"Guralnik JM, Cawthon PM, Bhasin S, Fielding R, Magaziner J, Cruz-Jentoft AJ et al (2023) Limited physician knowledge of sarcopenia: a survey. J Am Geriatr Soc 71:1595\u20131602. https:\/\/doi.org\/10.1111\/jgs.18227","journal-title":"J Am Geriatr Soc"},{"key":"1321_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac003","volume":"51","author":"C Hurst","year":"2022","unstructured":"Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C et al (2022) Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing 51:afac003. https:\/\/doi.org\/10.1093\/ageing\/afac003","journal-title":"Age Ageing"},{"key":"1321_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"1321_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA et al (2020) Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc 68:1410\u20131418. https:\/\/doi.org\/10.1111\/jgs.16372","journal-title":"J Am Geriatr Soc"},{"key":"1321_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300-307.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"1321_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.22540\/JFSF-04-071","volume":"4","author":"NJ Offord","year":"2019","unstructured":"Offord NJ, Clegg A, Turner G, Dodds RM, Sayer AA, Witham MD (2019) Current practice in the diagnosis and management of sarcopenia and frailty \u2013 results from a UK-wide survey. J Frailty Sarcopenia Falls 4:71\u201377. https:\/\/doi.org\/10.22540\/JFSF-04-071","journal-title":"J Frailty Sarcopenia Falls"},{"key":"1321_CR10","doi-asserted-by":"publisher","unstructured":"Caulfield L, Arnold S, Biase SD, Buckland C, Heslop P, Hurst C, et al. The Benchmarking Exercise Programme for Older People (BEPOP): Design, Results and Recommendations from The First Wave of Data Collection. J Frailty Sarcopenia Falls 2024;9:169\u201383. https:\/\/doi.org\/10.22540\/JFSF-09-169.","DOI":"10.22540\/JFSF-09-169"},{"key":"1321_CR11","doi-asserted-by":"publisher","unstructured":"Witham MD, Chawner M, De Biase S, Offord N, Todd O, Clegg A, et al. Content of exercise programmes targeting older people with sarcopenia or frailty \u2013 findings from a UK survey. J Frailty Sarcopenia Falls 2020;05:17\u201323. https:\/\/doi.org\/10.22540\/JFSF-05-017.","DOI":"10.22540\/JFSF-05-017"},{"key":"1321_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1186\/s12877-023-04461-5","volume":"23","author":"C Hurst","year":"2023","unstructured":"Hurst C, Dismore L, Granic A, Tullo E, Noble JM, Hillman SJ et al (2023) Attitudes and barriers to resistance exercise training for older adults living with multiple long-term conditions, frailty, and a recent deterioration in health: qualitative findings from the lifestyle in later life \u2013 older people\u2019s medicine (LiLL-OPM) study. BMC Geriatr 23:772. https:\/\/doi.org\/10.1186\/s12877-023-04461-5","journal-title":"BMC Geriatr"},{"key":"1321_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eurger.2015.12.009","volume":"7","author":"O Bruy\u00e8re","year":"2016","unstructured":"Bruy\u00e8re O, Beaudart C, Reginster J-Y, Buckinx F, Schoene D, Hirani V et al (2016) Assessment of muscle mass, muscle strength and physical performance in clinical practice: an international survey. Eur Geriatr Med 7:243\u2013246. https:\/\/doi.org\/10.1016\/j.eurger.2015.12.009","journal-title":"Eur Geriatr Med"},{"key":"1321_CR14","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1111\/ajag.12730","volume":"39","author":"SSY Yeung","year":"2020","unstructured":"Yeung SSY, Reijnierse EM, Trappenburg MC, Meskers CGM, Maier AB (2020) Current knowledge and practice of Australian and New Zealand health-care professionals in sarcopenia diagnosis and treatment: time to move forward! Australas J Ageing 39:e185\u2013e193. https:\/\/doi.org\/10.1111\/ajag.12730","journal-title":"Australas J Ageing"},{"key":"1321_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105132","volume":"115","author":"M Yamada","year":"2023","unstructured":"Yamada M, Lee W-J, Akishita M, Yang M, Kang L, Kim S et al (2023) Clinical practice for sarcopenia in Asia: online survey by the Asian Working Group for Sarcopenia. Arch Gerontol Geriatr 115:105132. https:\/\/doi.org\/10.1016\/j.archger.2023.105132","journal-title":"Arch Gerontol Geriatr"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01321-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:01:46Z","timestamp":1777017706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01321-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01321-w","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AAS and MDW are named collaborators on a research project with Regeneron Pharmaceuticals. AAS is involved in a collaborative research project with Pfizer and MDW has received consultancy fees for sarcopenia trial design from Rejuvenate Biomed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Following UK Health Research Authority (\n                      \n                      ) guidance, the project was not classified as research and so did not require research ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}